Aflibercept

Aflibercept 8 mg first to achieve sustained vision gains with more than 70% of patients extended to intervals between 16 and 24 weeks in wet age-related macular degeneration at two years

10 August 2023 | 12:59 PM Europe/Amsterdam Not intended for U.S. and UK Media – Two-year topline results from the…